Ascelia Pharma AB (publ) (STO:ACE)

Ascelia Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	406	281	114	503	1,005	1,590
Market Cap Growth	93.61%	146.68%	-77.38%	-49.95%	-36.78%	186.78%
Enterprise Value	354	212	76	324	716	1,370
Last Close Price	3.21	2.92	3.37	14.94	29.85	56.40
PB Ratio	4.34	3.56	1.53	2.78	3.27	6.74
P/TBV Ratio	11.09	12.83	6.59	4.06	4.01	8.88
Debt / Equity Ratio	0.09	0.32	0.01	0.00	0.01	0.01
Quick Ratio	2.07	1.31	1.98	4.12	10.65	10.21
Current Ratio	2.15	1.35	2.30	4.29	10.94	10.69
Return on Equity (ROE)	-134.06%	-104.43%	-85.65%	-53.70%	-46.30%	-41.72%
Return on Assets (ROA)	-47.20%	-37.35%	-45.59%	-33.44%	-29.27%	-23.06%
Return on Capital (ROIC)	-56.61%	-47.38%	-54.28%	-37.61%	-31.49%	-24.54%
Earnings Yield	-23.32%	-28.52%	-96.07%	-26.09%	-12.53%	-6.21%
FCF Yield	-17.42%	-22.39%	-111.45%	-24.90%	-11.60%	-5.41%
Buyback Yield / Dilution	-164.11%	-60.15%	3.10%	-5.58%	-25.46%	-20.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.